OR WAIT null SECS
May 04, 2022
The two companies signed an exclusive collaboration agreement for the Aidaptus auto-injector.
Standard BioTools’ new Hyperion+ Imaging System can process more samples and has lower limits of detection than their current product.
FDA granted Quanterix’s neurofilament light chain plasma test a breakthrough device designation as a prognostic aid for relapsing-remitting multiple sclerosis.
Accelerate Diagnostics’ new blood culture kit demonstrated 94% or greater accuracy on positive blood cultures relative to matrix-assisted laser desorption/ionization (MALDI).
April 29, 2022
Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels.
A new range of five instruments for ultra-low-volume liquid dispensing for microarray and microfluidics applications, Mercury, has been introduced by Arrayjet.
CN Bio’s PhysioMimix “in-a-box” reagent kit is designed to harness liver-on-a-chip technology to improve accuracy and efficiency in drug discovery.
April 28, 2022
Societal CDMO has been awarded a new manufacturing and packaging task order agreement by National Cancer Institute.
Thermo Fisher Scientific has expanded its state-of-the-art R&D facility in Hyderabad, India.
April 22, 2022
Catalent will invest $350 million into integrated biologics drug substance and drug product manufacturing at Bloomington, Indiana facility.